Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
Open Access
- 16 April 2011
- journal article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 6 (1) , 36
Abstract
Maspin is a unique member of the serine protease inhibitor superfamily and its expression is found in myoepithelial cells of normal mammary glands; therefore, it has been considered to be a myoepithelial marker. We previously reported that maspin was frequently expressed in biologically aggressive breast cancers. In turn, triple-negative (TN) breast cancer is a subtype of tumor with aggressive clinical behavior and shows frequent expression of basal markers. We hypothesized that maspin expression may be frequent and correlate with basal rather than myoepithelial markers in TN breast cancer.Keywords
This publication has 13 references indexed in Scilit:
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Basal-Like Breast Cancer: A Critical ReviewJournal of Clinical Oncology, 2008
- Biological functions of maspinJournal of Cellular Physiology, 2006
- Expression of wild‐type estrogen receptor β protein in human breast cancer: Specific correlation with HER2/neu overexpressionPathology International, 2006
- Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiationThe Journal of Pathology, 2006
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Expression of maspin is up‐regulated during the progression of mammary ductal carcinomaHistopathology, 2003
- Expression of maspin predicts poor prognosis in breast‐cancer patientsInternational Journal of Cancer, 2002
- CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiationBritish Journal of Cancer, 2001
- Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial CellsScience, 1994